fda update on tirzepatide Breaking News: OFA Challenges Shortage Ruling Breaking News: OFA Challenges FDA

Its about to get a lot harder to get cheap GLP-1s: Rising costs may force consumers to cut back on discretionary spending, creating headwinds for retailers already fearing tariff-driven cost increases.

Heres what stands out 1 Two Phase 2 wins, two different proof points Elecoglipron was evaluated in: #VISTA (Phase 2) 36-week weight-loss study vs placebo in 310 patients with obesity or overweight #SOLSTICE (Phase 2) glycemic control study vs placebo or semaglutide (active ingredient in Novo Nordisks #Wegovy) in 406 Type 2 diabetes patients Both studies hit their primary endpoints, clearing the bar for Phase 3

Compounded tirzepatide and Mounjaro contain the same active ingredient but differ in sourcing, price, and prescription flexibility

Remove the patch after at least four hours

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a persons risk of other health conditions.

Learn causes, natural prevention, and expert treatments to maintain a youthful, healthy look.